GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Patient Access Solutions PASO · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

-90.00%

Close of 3 Nov 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2021

Revenue

$212,736

FY2016FY2021

Net income

−$10.6m

FY2016FY2021

Free cash flow

−$10.3m

FY2016FY2021

Shareholders' equity

−$2.0m

FY2016FY2021

Income statement

Fiscal years

FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$212,736$504,143$937,812$1.9m$2.5m$650,930
Gross profit$212,736$504,142$935,027$1.9m$2.4m$650,930
Operating income−$9.0m−$7.0m$470,620$726,430−$1.4m$110,840
Net income−$10.6m−$7.3m$469,348$699,100−$1.6m$109,271
Diluted earnings per share-0.00-0.000.000.00-0.000.00

Balance sheet

At each fiscal year end

FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$489,193$647,088$2.8m$2.8m$2.2m$912,809
Cash and short-term investments$15,026$14,807$41,017−$62,051−$251,651$208,040
Total liabilities$2.4m$2.1m$731,912$777,531$1.1m$879,967
Debt$925,373$935,006$565,006$575,006$821,881$478,668
Shareholders' equity−$2.0m−$1.5m$2.0m$2.0m$1.1m$32,842
Shares outstanding2,277m2,477m2,477m2,477m2,477m2,477m

Cash flow

Fiscal years

FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−$10.3m$137,310$128,926−$649,853−$505$20
Capital spending−$4——−$4,489−$397−$397,000
Free cash flow−$10.3m$137,310$128,926−$654,342−$902−$396,980

Latest quarters

By quarter end

Jan 2022Oct 2021Apr 2021Jan 2012Apr 2011Jan 2011Oct 2010Jul 2009
Revenue$54,000$67,044$102,000$166,041$106,099$170,976$316,579$606,600
Gross profit$54,000$67,044$102,000$119,059$30,357$118,471$190,029—
Operating income$300−$8.6m−$300,250−$834−$52,363−$32,953−$74,769−$2.3m
Net income$303−$10.2m−$300,250$8,699−$72,487−$37,263−$126,841−$2.5m
Diluted earnings per share0.00-0.00-0.000.00-0.08-0.04-0.05-35.57
Cash from operations—−$9.0m——————
Total assets$504,146$489,193$4.9m$1.3m$715,299$792,562$798,934$854,800
Cash and short-term investments$24,278$15,026$133,241—————
Debt$418,566$392,412$565,006————$1.7m
Shareholders' equity−$1.9m−$2.0m$3.8m−$706,073−$1.9m−$1.9m−$1.9m−$2.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-51.4%-20.0%—
Operating income——154.2%
Net income——158.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin100.0%100.0%99.3%—
Operating margin-2232.9%-421.6%-242.9%—
Net margin-2501.1%-477.2%-275.2%—

Valuation history

At each fiscal year end

FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-0.2-3.414.912.5-51.1—
Price to sales9.649.17.44.732.7185.4

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%-33%-82%-93%289%114%-94%-38%824%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1000-to-1 reverse split · 9 Jan 2012
  • 7.25-for-1 split · 2 Jun 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.